At a glance
ClinicalIndex Comparison RecordN/ACompleted· 85 enrolled
Drug / intervention
Evoke radiofrequency devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment With the Evoke System for Facial and Submental Laxity
In Brief
A clinical study evaluating Evoke radiofrequency device for Laxity; Skin. Completed, enrolled 85 participants across 5 sites.
Detailed Summary
The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaxity; Skin
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartDec 2020
First PostedJan 2021
Primary CompletionJul 2022
Study CompletionJul 2022
TodayJul 2026
First PostedJan 22, 2021
Enrollment StartDec 1, 2020
Primary CompletionJul 15, 2022
Study CompletionJul 20, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.4 years ago
Interventions
Evoke radiofrequency devicedevice
Enrolled subjects will undergo up to 3 successive bi-weekly (every 2 weeks) treatments,